Tilray Wins Authorization to Sell Medical Cannabis in Portugal

222rqektkpTURBXy84NjYxYTY4ZjMyNzg1MTlmNzM5OTQzZTUwMWE4M2M-1-350x227-E8zNvT.jpeg
The regulatory approval bolsters the cannabis company’s ambitions to be a top player in the category. Tilray (NASDAQ:TLRY) has opened a new market for its medical marijuana. The company announced Monday that Portugal’s national healthcare regulator, Infarmed, has granted it authorization to sell its products in that country. “This is the first time a full quality dossier was required and delivered to obtain market authorization in Europe for a medical cannabis product,” Tilray wrote in…
0 0 vote
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Inline Feedbacks
View all comments
scroll to top
0
Would love your thoughts, please comment.x
()
x